US5041380A
(en)
*
|
1982-08-04 |
1991-08-20 |
La Jolla Cancer Research Foundation |
Tetrapeptide
|
US20030143733A1
(en)
*
|
1985-06-17 |
2003-07-31 |
La Jolla Cancer Research Foundation |
Tetrapeptide
|
ES2052595T3
(es)
*
|
1986-12-15 |
1994-07-16 |
Inst Nat Sante Rech Med |
Nuevos derivados peptidicos y su aplicacion en especial en terapeutica.
|
WO1989005150A1
(en)
*
|
1987-12-10 |
1989-06-15 |
La Jolla Cancer Research Foundation |
Conformationally stabilized cell adhesion peptides
|
US5827821A
(en)
*
|
1987-12-10 |
1998-10-27 |
The Burnham Institute |
Conformationally stabilized cell adhesion peptides
|
ZW6189A1
(en)
*
|
1988-05-09 |
1990-05-09 |
Smithkline Beckman Corp |
Anti-aggregatory peptides
|
US5037808A
(en)
*
|
1988-07-20 |
1991-08-06 |
Monsanto Co. |
Indolyl platelet-aggregation inhibitors
|
US4879313A
(en)
*
|
1988-07-20 |
1989-11-07 |
Mosanto Company |
Novel platelet-aggregation inhibitors
|
US5053393A
(en)
*
|
1988-07-20 |
1991-10-01 |
Monsanto Company |
Novel platelet-aggregation inhibitor
|
JPH04503951A
(ja)
*
|
1988-12-20 |
1992-07-16 |
ラ ホヤ キャンサー リサーチ ファウンデーション |
創傷治癒に活性のあるポリペプチド―ポリマー複合体
|
US5654267A
(en)
*
|
1988-12-20 |
1997-08-05 |
La Jolla Cancer Research Center |
Cooperative combinations of ligands contained within a matrix
|
CA2008116C
(en)
*
|
1989-02-23 |
2001-11-20 |
Thomas Weller |
Glycine derivatives
|
US5795867A
(en)
*
|
1989-06-16 |
1998-08-18 |
Cor Therapeutics, Inc. |
Platelet aggregation inhibitors
|
US5318899A
(en)
*
|
1989-06-16 |
1994-06-07 |
Cor Therapeutics, Inc. |
Platelet aggregation inhibitors
|
US5344783A
(en)
*
|
1989-06-16 |
1994-09-06 |
Cor Therapeutics, Inc. |
Platelet aggregation inhibitors
|
US5686568A
(en)
*
|
1989-06-16 |
1997-11-11 |
Cor Therapeutics, Inc. |
Platelet aggregration inhibitors
|
US5384309A
(en)
|
1989-07-17 |
1995-01-24 |
Genentech, Inc. |
Cyclized peptides and their use as platelet aggregation inhibitors
|
US5061693A
(en)
*
|
1989-07-28 |
1991-10-29 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5328840A
(en)
*
|
1989-08-15 |
1994-07-12 |
The Research Foundation Of The State University Of New York |
Method for preparing targeted carrier erythrocytes
|
US5120859A
(en)
*
|
1989-09-22 |
1992-06-09 |
Genentech, Inc. |
Chimeric amino acid analogues
|
US5332726A
(en)
*
|
1989-09-29 |
1994-07-26 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Antithrombotic peptides and pseudopeptides
|
US4952562A
(en)
*
|
1989-09-29 |
1990-08-28 |
Rorer Pharmaceutical Corporation |
Anti-thrombotic peptides and pseudopeptides
|
WO1991004746A1
(en)
*
|
1989-09-29 |
1991-04-18 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Anti-thrombotic peptides and pseudopeptides
|
US5051405A
(en)
*
|
1989-10-10 |
1991-09-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Anti-thrombotic peptides and pseudopeptides
|
US5338723A
(en)
*
|
1989-10-13 |
1994-08-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
NZ235564A
(en)
*
|
1989-10-13 |
1993-10-26 |
Merck & Co Inc |
Fibrinogen receptor antagonist and pharmaceutical compositions
|
US5643872A
(en)
*
|
1989-10-23 |
1997-07-01 |
Smithkline Beecham Corporation |
Cyclic anti-aggregatory peptides
|
US5053392A
(en)
*
|
1989-12-01 |
1991-10-01 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
|
US5612311A
(en)
*
|
1990-04-06 |
1997-03-18 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5648330A
(en)
*
|
1990-04-06 |
1997-07-15 |
La Jolla Cancer Research Foundation |
Method and composition for treating vascular graft occlusion
|
US6521594B1
(en)
|
1990-04-06 |
2003-02-18 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
WO1991015515A1
(en)
*
|
1990-04-06 |
1991-10-17 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5672585A
(en)
*
|
1990-04-06 |
1997-09-30 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5780303A
(en)
*
|
1990-04-06 |
1998-07-14 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
WO1992007872A1
(en)
*
|
1990-10-29 |
1992-05-14 |
California Institute Of Biological Research |
Tenascin related peptides
|
EP0557406A4
(en)
*
|
1990-11-01 |
1993-10-06 |
Smith-Kline Beecham Corporation |
-g(g)-turn peptidomimetics as fibrinogen antagonists
|
US5179082A
(en)
*
|
1990-11-13 |
1993-01-12 |
Merck & Co., Inc. |
Method for blocking platelet adhesion to collagen
|
US5561220A
(en)
*
|
1991-02-08 |
1996-10-01 |
Diatech, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
US6107459A
(en)
*
|
1991-02-08 |
2000-08-22 |
Diatide, Inc. |
Technetium-99m labeled peptides for diagnostic imaging
|
US6019958A
(en)
*
|
1991-02-08 |
2000-02-01 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
US5645815A
(en)
*
|
1991-02-08 |
1997-07-08 |
Diatide, Inc. |
Radiolabled compounds for thrombus imaging
|
DE69230525T2
(de)
*
|
1991-02-08 |
2000-06-21 |
Diatide Inc |
Technetium-99m markierte Polypeptide zur Bildformung
|
US5481021A
(en)
*
|
1991-03-06 |
1996-01-02 |
G. D. Searle & Co. |
Phenyl amidines derivatives useful as platelet aggregation inhibitors
|
DK0578728T3
(da)
*
|
1991-04-05 |
1999-04-12 |
Genentech Inc |
Inhibitorer for aggregering af blodplader, hvilke inhibitorer har høj specificitet for GP IIbIIIa
|
WO1992018117A1
(en)
*
|
1991-04-11 |
1992-10-29 |
Rhone-Poulenc Rorer International (Holdings), Inc. |
Anti-thrombotic peptide and pseudopeptide derivatives
|
DE69213546T2
(de)
*
|
1991-05-13 |
1997-02-27 |
Fujisawa Pharmaceutical Co |
Neue Peptid-Verbindungen und Verfahren zur Herstellung davon
|
US5220050A
(en)
*
|
1991-05-17 |
1993-06-15 |
G. D. Searle & Co. |
Peptide mimetic compounds useful as platelet aggregation inhibitors
|
AU2296792A
(en)
*
|
1991-06-28 |
1993-01-25 |
Corvas International, Inc. |
Novel inhibitors of platelet aggregation
|
DE4126277A1
(de)
*
|
1991-08-08 |
1993-02-11 |
Cassella Ag |
Hydantoinderivate
|
IL103252A
(en)
|
1991-09-30 |
1997-03-18 |
Du Pont Merck Pharma |
CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
US5635477A
(en)
*
|
1991-09-30 |
1997-06-03 |
The Dupont Merck Pharmaceutical Company |
Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
|
US5239113A
(en)
*
|
1991-10-15 |
1993-08-24 |
Monsanto Company |
Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
|
US5625093A
(en)
*
|
1991-10-15 |
1997-04-29 |
G. D. Searle & Co. |
Substituted β-amino acid derivatives useful as platelet aggregation inhibitors
|
US5254573A
(en)
*
|
1991-10-15 |
1993-10-19 |
Monsanto Company |
Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
|
AU3064892A
(en)
*
|
1991-11-07 |
1993-06-07 |
University Of Southern California |
Compositions and methods for preventing adhesion formation
|
WO1993012103A1
(en)
*
|
1991-12-13 |
1993-06-24 |
G.D. Searle & Co. |
Phenyl amidines lactones useful as platelet aggregation inhibitors
|
US5424334A
(en)
*
|
1991-12-19 |
1995-06-13 |
G. D. Searle & Co. |
Peptide mimetic compounds useful as platelet aggregation inhibitors
|
US5264457A
(en)
*
|
1992-02-14 |
1993-11-23 |
G. D. Searle & Co. |
Phenyl amidines sulfonamides useful as platelet aggregation inhibitors
|
LT3284B
(en)
|
1992-04-23 |
1995-06-26 |
Merck & Co Inc |
Fibrinogen receptor antagonists
|
AU4540693A
(en)
*
|
1992-06-25 |
1994-01-24 |
G.D. Searle & Co. |
Phenyl amidine alkanoic acids and lactones useful as platelet aggregation inhibitors
|
CA2101599A1
(en)
*
|
1992-08-31 |
1994-03-01 |
Wilhelm Bannwarth |
Tri- and tetracyclic compounds
|
EP0672059A1
(de)
*
|
1992-11-18 |
1995-09-20 |
The Du Pont Merck Pharmaceutical Company |
Durch eine heteroringverbindung verbundene zyclische verbindungen mit plaettchen glycoprotein iib/iiia hemmung
|
US5409939A
(en)
*
|
1993-02-12 |
1995-04-25 |
G. D. Searle & Co. |
Phenyl amidine thio derivatives useful as platelet aggregation inhibitors
|
US5614106A
(en)
*
|
1993-03-12 |
1997-03-25 |
Baxter International Inc. |
Method and apparatus for collection of platelets
|
WO1994021602A1
(en)
*
|
1993-03-15 |
1994-09-29 |
G.D. Searle & Co. |
Urea derivatives useful as platelet aggregation inhibitors
|
US5612355A
(en)
*
|
1993-06-23 |
1997-03-18 |
G. D. Searle & Co. |
Phenyl amidine lactones useful as platelet aggregation inhibitors
|
US5780590A
(en)
*
|
1993-10-15 |
1998-07-14 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
|
EP0812205B1
(de)
*
|
1993-10-15 |
2001-03-14 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Antithrombotisch wirkende azacycloalkyl-alkanoyl-peptide und-pseudopeptide
|
US5770575A
(en)
*
|
1994-03-16 |
1998-06-23 |
Ortho Pharmaceutical Corporation |
Nipecotic acid derivatives as antithrombotic compounds
|
US6387880B1
(en)
|
1994-10-24 |
2002-05-14 |
G.D. Searle & Co. |
Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L-α-aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts
|
US5602155A
(en)
*
|
1995-01-17 |
1997-02-11 |
G. D. Searle & Co. |
Platelet aggregation inhibitors
|
US5639765A
(en)
*
|
1995-01-17 |
1997-06-17 |
G. D. Searle & Co. |
Guanidinoalkyl glycine β-amino acids useful for inhibiting bone loss
|
US5674894A
(en)
*
|
1995-05-15 |
1997-10-07 |
G.D. Searle & Co. |
Amidine derivatives useful as platelet aggregation inhibitors and vasodilators
|
US5681820A
(en)
*
|
1995-05-16 |
1997-10-28 |
G. D. Searle & Co. |
Guanidinoalkyl glycine β-amino acids useful for inhibiting tumor metastasis
|
SK21999A3
(en)
*
|
1996-08-21 |
2000-02-14 |
Rhone Poulenc Rorer Pharma |
Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin- -4-yl)butanoyl)-n-ethylglycyl] compounds
|
AP1390A
(en)
*
|
1996-11-27 |
2005-04-15 |
Aventis Pharmaceuticals Products Inc |
Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound.
|
US5932693A
(en)
*
|
1996-12-10 |
1999-08-03 |
Washington University |
Antithrombotic peptides
|
AP1224A
(en)
|
1998-03-19 |
2003-11-14 |
Bristol Myers Squibb Co |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
|
CN103153288B
(zh)
|
2010-07-09 |
2017-02-15 |
詹姆斯·特林卡·格林 |
用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统
|